NCT06827327View on ClinicalTrials.gov

LC-Plasma for Preventing URTIs and Reducing Symptoms

PHASE3RecruitingINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

March 28, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Healthy VolunteerURTI
Interventions
DIETARY_SUPPLEMENT

LC-Plasma

1 tablet containing 50mg LC-Plasma is taken daily for 24 weeks

OTHER

Placebo

1 tablet containing 50mg MCC is taken daily for 24 weeks

Trial Locations (1)

4006

RECRUITING

RDC Clinical, Brisbane

All Listed Sponsors
collaborator

Kirin Holdings Company, Limited

INDUSTRY

lead

RDC Clinical Pty Ltd

INDUSTRY